A double-blind, placebo-controlled trial of i.v. dolasetron mesilate in the prevention of radiotherapy-induced nausea and vomiting in cancer patients. [electronic resource]
Producer: 19970204Description: 378-83 p. digitalISSN:- 0941-4355
- Adult
- Aged
- Analysis of Variance
- Antiemetics -- administration & dosage
- Double-Blind Method
- Female
- Humans
- Indoles -- administration & dosage
- Injections, Intravenous
- Linear Models
- Male
- Middle Aged
- Nausea -- etiology
- Neoplasms -- pathology
- Quinolizines -- administration & dosage
- Radiotherapy, High-Energy -- adverse effects
- Treatment Outcome
- Vomiting -- etiology
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.